Renub

    Messenger RNA (mRNA) Vaccines & Therapeutics Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis

    Excel: 12 Hours
    PDF: 24 Hours
    Nov 2022
    Pages: 125

    Messenger RNA (mRNA) Vaccines & Therapeutics Market Outlook

    Global Messenger RNA (mRNA) Vaccines & Therapeutics Market will reach US$ 26.34 Billion by 2028. Messenger Ribonucleic Acid (mRNA) is a term that refers to a single protein-coding gene in the genome that conforms as the basis for protein synthesis in cells. mRNA vaccines and treatments are made in laboratories utilizing mammalian cells and have favorable immunological characteristics. Infection prevention mRNA vaccines, infectious disease treatment mRNA vaccines, customized cancer therapy mRNA vaccines, and standardization of cancer treatment mRNA vaccines are frequent types of vaccinations and therapies. They are injected into the body to activate virus-detecting immunological sensors and cause the cells to generate viral antigen proteins. This improves B- and T-cell responses, which helps the body's immunity.

    mrna-vaccines-therapeutics-market


    Global Messenger RNA (mRNA) Vaccines & Therapeutics Market Size will expand at a CAGR of 14.60% from 2022 to 2028:

    mRNA vaccines and treatments are generated employing new technologies that are more effective against infections, have higher potency, improved immunogenicity, and are relatively more cost-effective than conventional pharmaceuticals. One of the critical factors propelling the development of the Global Messenger RNA (mRNA) Vaccines & Therapeutics Market is the increased prevalence of medical disorders such as diabetes, TB, cancer, and cardiovascular diseases (CVDs). In addition, the industry also benefits from rising demand for therapeutic drugs and vaccines for Ebola, influenza, HIV, and other viral illnesses.


    Evolution of the Global Messenger RNA (mRNA) Vaccines & Therapeutics Industry amidst Pandemic:

    With the launch and widespread usage of mRNA vaccines and therapies for COVID-19, 2020 marked a watershed moment for mRNA technology platforms. As a result, the combined market valuation of mRNA platforms had increased fast by 2020. The increase in market value reflects expectations that mRNA technology will give far more than the current COVID-19 preventive vaccines. According to Renub Research, the Global Messenger RNA (mRNA) Vaccines and Therapeutics Market was valued at US$ 11.63 Billion in 2022.


    Global Messenger RNA (mRNA) Vaccines & Therapeutics Market: Segmentation Analysis:

    • By Type, the market is bifurcated into Infection Prevention mRNA Vaccine, Infectious Disease Treatment mRNA Vaccine, Individualized Cancer Treatment mRNA Vaccine, and Standardization of Cancer Treatment mRNA Vaccine.

    • By Application, Cancer, Infectious Diseases, and Others are the major segments covered in our report. As per our estimates, Infectious Diseases hold a significant share in the market and are estimated to remain dominant throughout the forecasted period.

    • By End User, we have studied the market for hospitals, Clinics, Diagnostics Centers, and Others. As per our analysis, clinics and diagnostic centers are gaining traction with the advancement of technology applications. However, hospitals tend to remain dominant throughout the study period.

    • By Region, North America, Europe, Asia-Pacific, and Rest of the World. During the forecast period, North America is estimated to monopolize the Global Messenger RNA (mRNA) Vaccines & Therapeutics Market. The market in North America is contrived by an increase in demand for COVID-19 mRNA vaccines, major players operating in the US, and an exponential rise in the number of COVID-19 cases in the US.


    Key Players:

    Pfizer, GlaxoSmithKline, Daiichi Sankyo Company, Limited, Intellia Therapeutics, Moderna Inc, CureVac N.V., Arcturus Therapeutics Holdings, and BioNTech are the prominent companies in the Global Messenger RNA (mRNA) Vaccines & Therapeutics Market examined in our analysis. In addition, we have discussed the competition landscape section of the study, which included an overview, the latest development strategies, and market revenue analysis of the above-mentioned worldwide companies. Surprisingly, the major firms invest in mRNA technologies since they can integrate numerous molecules into a therapeutic drug, which is a huge growth factor.


    Renub Research latest report “Global Messenger RNA (mRNA) Vaccines & Therapeutics Market, Global Forecast By Type (Infection Prevention mRNA Vaccine, Infectious Disease Treatment mRNA Vaccine, Individualized Cancer Treatment mRNA Vaccine and Standardization of Cancer Treatment mRNA Vaccine), Application (Cancer, Infectious Diseases and Others), End User (Hospital, Clinics, Diagnostics Centers and Others), Region (North America, Europe, Asia-Pacific and Rest of the World), Companies (Pfizer, GlaxoSmithKline, Daiichi Sankyo Company, Limited, Intellia Therapeutics, Moderna Inc, CureVac N.V., Arcturus Therapeutics Holdings, and BioNTech)” provides a detailed analysis of Global Messenger RNA (mRNA) Vaccines & Therapeutics Industry.

     

    mrna-vaccines-therapeutics-market-share

     

    Type - The market has been studied from 4 viewpoints:

    1.    Infection Prevention mRNA Vaccine
    2.    Infectious Disease Treatment mRNA Vaccine
    3.    Individualized Cancer Treatment mRNA Vaccine
    4.    Standardization of Cancer Treatment mRNA Vaccine


    Application - The market has been studied from 3 viewpoints:

    1.    Cancer
    2.    Infectious Diseases
    3.    Others


    End Use - The market has been studied from 4 viewpoints:

    1.    Hospital
    2.    Clinics
    3.    Diagnostics Centers
    4.    Others


    Region - The market has been studied from 4 viewpoints:

    1.    North America
    2.    Europe
    3.    Asia-Pacific
    4.    Rest of the World


    Company Insights:

    •    Overview
    •    Recent Development
    •    Revenue


    Key Players:

    1.    Pfizer
    2.    GlaxoSmithKline's
    3.    Daiichi Sankyo Company, Limited.
    4.    Intellia Therapeutics
    5.    Moderna Inc
    6.    CureVac N.V.
    7.    Arcturus Therapeutics Holdings
    8.    BioNTech


    Report Details:

    Report Features Details
    Base Year 2022
    Historical Period 2017 - 2022
    Forecast Period 2023 - 2028
    Market US$ Billion
    Segment Covered Type, Application, End User, Region
    Regions Covered North America, Europe, Asia Pacific, and Rest of the World
    Companies Covered Pfizer, GlaxoSmithKline, Daiichi Sankyo Company Limited, Intellia Therapeutics, Moderna Inc, CureVac N.V., Arcturus Therapeutics Holdings, and BioNTech
    Customization Scope 20% Free Customization
    Post-Sale Analyst Support 1 Year (52 Weeks)
    Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request)


    Frequently Asked Questions:

    1.    What are the key driving factors for the growth of the market?
    2.    Who are the top players operating in the market?
    3.    By Application, how is the Cancer segment performing during the study period?
    4.    By Type, what segments are covered in the report?
    5.    What is the effect of pandemic on the industry?

    1.    Introduction

    2.    Research& Methodology

    3.    Executive Summary

    4.    Market Dynamics

    4.1    Growth Drivers
    4.2    Challenges
    4.3    Opportunities


    5.    Global Messenger RNA (mRNA) Vaccines & Therapeutics Market

    6.    Share Analysis – Global Messenger RNA (mRNA) Vaccines & Therapeutics Market

    6.1    By Type
    6.2    By Application
    6.3    By End User
    6.4    By Region


    7.    Type - Global Messenger RNA (mRNA) Vaccines & Therapeutics Market

    7.1    Infection Prevention mRNA Vaccine
    7.2    Infectious Disease Treatment mRNA Vaccine
    7.3    Individualized Cancer Treatment mRNA Vaccine
    7.4    Standardization of Cancer Treatment mRNA Vaccine


    8.    Application - Global Messenger RNA (mRNA) Vaccines & Therapeutics Market

    8.1    Cancer
    8.2    Infectious Diseases
    8.3    Others


    9.    End User - Global Messenger RNA (mRNA) Vaccines & Therapeutics Market

    9.1    Hospital
    9.2    Clinics
    9.3    Diagnostics Centers
    9.4    Others


    10.    Region - Global Messenger RNA (mRNA) Vaccines & Therapeutics Market

    10.1    North America
    10.2    Europe
    10.3    Asia-Pacific
    10.4    Rest of the World


    11.    Key Players

    11.1    Pfizer

    11.1.1    Overview
    11.1.2    Recent Development
    11.1.3    Revenue

    11.2    GlaxoSmithKline's

    11.2.1    Overview
    11.2.2    Recent Development
    11.2.3    Revenue

    11.3    Daiichi Sankyo Company, Limited.

    11.3.1    Overview
    11.3.2    Recent Development
    11.3.3    Revenue

    11.4    Intellia Therapeutics

    11.4.1    Overview
    11.4.2    Recent Development
    11.4.3    Revenue

    11.5    Moderna Inc

    11.5.1    Overview
    11.5.2    Recent Development
    11.5.3    Revenue

    11.6    CureVac N.V.

    11.6.1    Overview
    11.6.2    Recent Development
    11.6.3    Revenue

    11.7    Arcturus Therapeutics Holdings

    11.7.1    Overview
    11.7.2    Recent Development
    11.7.3    Revenue

    11.8    BioNTech

    11.8.1    Overview
    11.8.2    Recent Development
    11.8.3    Revenue


    List of Figures:

    Figure-01:    Global – Messenger RNA (mRNA) Vaccines & Therapeutics Market (Billion US$), 2017 – 2022
    Figure-02:    Global – Forecast for Messenger RNA (mRNA) Vaccines & Therapeutics Market (Billion US$), 2023 – 2028
    Figure-03:    Type – Infection Prevention mRNA Vaccine Market (Million US$), 2017 – 2022
    Figure-04:    Type – Forecast for Infection Prevention mRNA Vaccine Market (Million US$), 2023 – 2028
    Figure-05:    Type – Infectious Disease Treatment mRNA Vaccine Market (Million US$), 2017 – 2022
    Figure-06:    Type – Forecast for Infectious Disease Treatment mRNA Vaccine Market (Million US$), 2023 – 2028
    Figure-07:    Type – Individualized Cancer Treatment mRNA Vaccine Market (Million US$), 2017 – 2022
    Figure-08:    Type – Forecast for Individualized Cancer Treatment mRNA Vaccine Market (Million US$), 2023 – 2028
    Figure-09:    Type – Standardization of Cancer Treatment mRNA Vaccine Market (Million US$), 2017 – 2022
    Figure-10:    Type – Forecast for Standardization of Cancer Treatment mRNA Vaccine Market (Million US$), 2023 – 2028
    Figure-11:    Application – Cancer Market (Million US$), 2017 – 2022
    Figure-12:    Application – Forecast for Cancer Market (Million US$), 2023 – 2028
    Figure-13:    Application – Infectious Diseases Market (Million US$), 2017 – 2022
    Figure-14:    Application – Forecast for Infectious Diseases Market (Million US$), 2023 – 2028
    Figure-15:    Application – Others Market (Million US$), 2017 – 2022
    Figure-16:    Application – Forecast for Others Market (Million US$), 2023 – 2028
    Figure-17:    End User – Hospital Market (Million US$), 2017 – 2022
    Figure-18:    End User – Forecast for Hospital Market (Million US$), 2023 – 2028
    Figure-19:    End User – Clinics Market (Million US$), 2017 – 2022
    Figure-20:    End User – Forecast for Clinics Market (Million US$), 2023 – 2028
    Figure-21:    End User – Diagnostics Centers Market (Million US$), 2017 – 2022
    Figure-22:    End User – Forecast for Diagnostics Centers Market (Million US$), 2023 – 2028
    Figure-23:    End User – Others Market (Million US$), 2017 – 2022
    Figure-24:    End User – Forecast for Others Market (Million US$), 2023 – 2028
    Figure-25:    North America – Messenger RNA (mRNA) Vaccines & Therapeutics Market (Million US$), 2017 – 2022
    Figure-26:    North America – Forecast for Messenger RNA (mRNA) Vaccines & Therapeutics Market (Million US$), 2023 – 2028
    Figure-27:    Europe – Messenger RNA (mRNA) Vaccines & Therapeutics Market (Million US$), 2017 – 2022
    Figure-28:    Europe – Forecast for Messenger RNA (mRNA) Vaccines & Therapeutics Market (Million US$), 2023 – 2028
    Figure-29:    Asia-Pacific – Messenger RNA (mRNA) Vaccines & Therapeutics Market (Million US$), 2017 – 2022
    Figure-30:    Asia-Pacific – Forecast for Messenger RNA (mRNA) Vaccines & Therapeutics Market (Million US$), 2023 – 2028
    Figure-31:    Rest of the World – Messenger RNA (mRNA) Vaccines & Therapeutics Market (Million US$), 2017 – 2022
    Figure-32:    Rest of the World – Forecast for Messenger RNA (mRNA) Vaccines & Therapeutics Market (Million US$), 2023 – 2028
    Figure-33:    Pfizer – Global Revenue (Billion US$), 2017 – 2022
    Figure-34:    Pfizer – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-35:    GlaxoSmithKline's – Global Revenue (Billion US$), 2017 – 2022
    Figure-36:    GlaxoSmithKline's – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-37:    Daiichi Sankyo Company, Limited. – Global Revenue (Billion US$), 2017 – 2022
    Figure-38:    Daiichi Sankyo Company, Limited. – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-39:    Intellia Therapeutics – Global Revenue (Million US$), 2017 – 2022
    Figure-40:    Intellia Therapeutics – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-41:    Moderna Inc – Global Revenue (Million US$), 2017 – 2022
    Figure-42:    Moderna Inc – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-43:    CureVac N.V. – Global Revenue (Million US$), 2017 – 2022
    Figure-44:    CureVac N.V. – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-45:    Arcturus Therapeutics Holdings – Global Revenue (Million US$), 2017 – 2022
    Figure-46:    Arcturus Therapeutics Holdings – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-47:    BioNTech – Global Revenue (Million US$), 2017 – 2022
    Figure-48:    BioNTech – Forecast for Global Revenue (Million US$), 2023 – 2028


    List of Tables:

    Table-01:    Global – Messenger RNA (mRNA) Vaccines & Therapeutics Market Share by Type (Percent), 2017 – 2022
    Table-02:    Global – Forecast for Messenger RNA (mRNA) Vaccines & Therapeutics Market Share by Type (Percent), 2023 – 2028
    Table-03:    Global – Messenger RNA (mRNA) Vaccines & Therapeutics Market Share by Application (Percent), 2017 – 2022
    Table-04:    Global – Forecast for Messenger RNA (mRNA) Vaccines & Therapeutics Market Share by Application (Percent), 2023 – 2028
    Table-05:    Global – Messenger RNA (mRNA) Vaccines & Therapeutics Market Share by End User (Percent), 2017 – 2022
    Table-06:    Global – Forecast for Messenger RNA (mRNA) Vaccines & Therapeutics Market Share by End User (Percent), 2023 – 2028
    Table-07:    Global – Messenger RNA (mRNA) Vaccines & Therapeutics Market Share by Region (Percent), 2017 – 2022
    Table-08:    Global – Forecast for Messenger RNA (mRNA) Vaccines & Therapeutics Market Share by Region (Percent), 2023 – 2028

    • Description
      Price
    • Chapter 7     Pages : 14
      $600
    • Chapter 8     Pages : 10
      $500
    • Chapter 9     Pages : 14
      $600
    • Chapter 10     Pages : 14
      $600
    • Chapter 11.1     Pages : 5
      $150
    • Chapter 11.3     Pages : 5
      $150
    • Chapter 11.4     Pages : 5
      $150
    • Chapter 11.5     Pages : 5
      $150
    • Chapter 11.6     Pages : 5
      $150
    • Chapter 11.7     Pages : 5
      $150
    • Chapter 11.8     Pages : 5
      $150

    Related Reports